Get Help With Your Dow Corning Breast Implant Claim in: Flagstaff, Sedona, Phoenix, Prescott, Show low, Sierra Vista, Tucson, Yuma and all of Arizona.
June 3, 2019 Deadline To Submit Disease Or Expedited Release Claim
Time is of the essence! If you are registered with the SF-DCT and have not submitted your disease claim, please contact our office for an explanation of the benefits available to you.
Dow Corning/SF-DCT Registration deadline has passed. If you are not sure of your status, you owe it to yourself to call us and find out about your rights within the SF-DCT.
There is no obligation to use our services, and YOU PAY NO FEE UNLESS YOU ARE AWARDED A SETTLEMENT.
Status Of Premium Payments
We do not have an update on when the Finance Committee will make a recommendation to pay the partial Premium Payments to claimants whose payment was stopped because of the ruling by the Court of Appeals for the Sixth Circuit. The Claimant Advisory Committee strongly believes – and has urged the Finance Committee – that these payments should be made immediately. We are hopeful that they will file a recommendation with the Court sometime this year. Once a recommendation is filed, the District Court must still approve it.
There is no update on when the final 50% Premium Payment will be made.
Increased Severity Claims
The Claims Office is now accepting claim filings for “Increased Severity”. You may qualify for an additional settlement if:
Your disease claim was approved in Disease Option 1 (such as ACTD or ANDS disease claims), AND your disease now qualifies for Severity Level A (100% total disability);
Your disease claim was approved in Disease Option 2. You can apply for an Increased Severity Level if you now have a disease or condition that qualifies for a higher level payment.
The deadline to file for Increased Severity claims is June 3, 2019.
Diseases and Complications
Are you suffering from symptoms of or have been diagnosed with:
- Lupus (SLE),
- peripheral neuropathy,
- chronic fatigue,
The FDA Issued a warning that Breast implants linked to rare cancer
Federal health officials issued a warning that breast implants may increase the risk of developing a very rare form of lymphoma.
The Food and Drug Administration has previously announced it had detected a possible association between saline and silicone gel-filled breast implants and anaplastic large cell lymphoma (ALCL), a cancer of the immune system.”Although very rare, the FDA believes women with breast implants may have a small increased risk of developing ALCL,” said William Maisel, the FDA’s chief scientist and deputy director of science in the agency’s Center for Devices and Radiological Health.
For more information regarding your Breast implant Claim Contact the Breast Implant Helpine